Clinical Study on Carotid Artery Injection of Ligustrazine Phosphate Injection for Cerebral Infarction
|更新时间:2024-01-04
|
Clinical Study on Carotid Artery Injection of Ligustrazine Phosphate Injection for Cerebral Infarction
Chinese Journal of Experimental Traditional Medical FormulaeVol. 17, Issue 6, Pages: 243-246(2011)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2011
稿件说明:
移动端阅览
ZANG Li, ZANG Tao. Clinical Study on Carotid Artery Injection of Ligustrazine Phosphate Injection for Cerebral Infarction[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(6): 243-246.
DOI:
ZANG Li, ZANG Tao. Clinical Study on Carotid Artery Injection of Ligustrazine Phosphate Injection for Cerebral Infarction[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(6): 243-246.DOI:
Clinical Study on Carotid Artery Injection of Ligustrazine Phosphate Injection for Cerebral Infarction
Objective: To study the clinical efficacy of carotid artery injection of ligustrazine phosphate injection for treatment of cerebral infarction. Method: Two-hunrend and fourty patients (45 to 65 years) surffered from cerebal infarction were randomized into treatment group (120 cases) and control group (120 cases). Treatment group was taken with the convientional treatment supplemented with carotid artery injection of ligustrazine phosphate
and the control group was only taken convientional treatment supplemented with vein injection of ligustrazine phosphate. Two groups were observed with integrated effects
neurological deficit score
area of cerebral infarction etc
before and after treatment. Result: The total effective rate of carotid artery injection was 94.2% (113/120). The total effective rate of the control group was 85.8% (103/120). No case with adverse reactions was found in treatment group. The neurological deficit score and area of cerebral infarction in the treatment group was better than that in the control group (P<0.05). The shorter the disease history
the better the treatment showed. Conclusion: Carotid artery injection of phosphate ligustrazine can reduce neurological deficit score and area of cerebral infarction.
Establishment and Evaluation of Mouse Model of Cerebral Infarction with Qi and Yin Deficiency Syndrome Based on Metabolomics
Clinical Evidence of Oral Chinese Patent Medicine for Ischemic Stroke: A Scoping Review
Common Syndromes of Cerebral Infarction Patients in Rural Areas of Eastern Henan Based on Latent Structure Model and Factor Analysis
Therapeutic Effect of Huangqi Chifengtang on Cerebral Infarction Rat Model and Its Effect on Expression of ZO-1, Claudin-5, P-gp and MRP1 Protein in Brain Tissue
Clinical Study on Modified Guipitang Combined with Xuefu Zhuyutang in Treating Mild Cognitive Impairment After Cerebral Infarction
Related Author
REN Junguo
YUAN Yue
GAO Yunxiao
ZHANG Qiuyan
CHEN Xiaoxiao
SHI Yali
LIU Jianxun
HU Longxiao
Related Institution
Natural History Museum of China
Beijing Key Laboratory of Chinese Materia Pharmacology,National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases,Institute of Basic Medical Sciences, Xiyuan Hospital,China Academy of Chinese Medical Sciences
Beijing University of Chinese Medicine Third Affiliated Hospital
China Institute for Brain Disorders,Beijing University of Chinese Medicine
Dongzhimen Hospital, Beijing University of Chinese Medicine